(Q30888770)

27 June 2017

1 reference

title

Immunomodulation by the copolymer glatiramer acetate (English)

1 reference

27 June 2017

1

Ruth Arnon

1 reference

27 June 2017

Michael Sela

2

1 reference

27 June 2017

publication date

1 November 2003

1 reference

Journal of Molecular Recognition

27 June 2017

published in

1 reference

27 June 2017

volume

16

1 reference

27 June 2017

issue

6

1 reference

27 June 2017

page(s)

412-421

1 reference

Immunogenic potentials of copolymer I in normal human lymphocytes

27 June 2017

cites work

1 reference

Human cellular immune response to copolymer I and myelin basic protein

21 January 2018

1 reference

Human and murine CD4 T cell reactivity to a complex antigen: recognition of the synthetic random polypeptide glatiramer acetate

21 January 2018

1 reference

Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group

21 January 2018

1 reference

Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability. Copolymer 1 Multiple Sclerosis Study Group

21 January 2018

1 reference

Practical issues in the management of multiple sclerosis. Introduction

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JMR.628

1 reference

27 June 2017

1 reference